Rhythm Pharmaceuticals is transitioning from a development stage to a commercial rare disease leader, leveraging its IMCIVREE ...

The trial is expected to recruit around 100 healthy overweight or obese volunteers.

A US-based study finds that 1 in 40 patients with obesity undergoing major surgery develop venous thromboembolism within 90 ...

As obesity rates continue to climb in the US, clinicians across specialties are confronting the reality that although ...

Strategies for Accommodating Obese Patients in 7 Areas of an Acute Care Setting Given the statistical trend toward obesity in the general population and the skyrocketing increase in bariatric surgical ...

A new study suggests using body mass index alone may miss many people with the disease, but the findings come with caveats.

After trial flops in spinal muscular atrophy, depression and bipolar disorder—and a costly rare disease drug ...

Metabolic health is a central concept in obesity medicine, yet it is often misunderstood or reduced to weight alone.For ...

People with comorbid alcohol use disorder and obesity may represent a distinct clinical subgroup, with glucose dysregulation ...

Doctors say obesity is complex, and advanced treatments like ESG and gastric balloons may help when traditional diets fail.

Award-Winning Study Surfaces Notable Gaps Between How Patients and Primary Care Physicians Approach Obesity Care ...

Zuellig Pharma expands obesity and diabetes advocacy with patient group partnership in PHL. BMPlus; June 2, 2026; 3 minute ...